Inhibiting the P2X4 receptor suppresses prostate cancer growth in vitro and in vivo, suggesting a potential clinical target

He, J., Zhou, Y., Arredondo Carrera, H.M. et al. (7 more authors) (2020) Inhibiting the P2X4 receptor suppresses prostate cancer growth in vitro and in vivo, suggesting a potential clinical target. Cells, 9 (11). 2511.

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2020 The Authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Keywords: ATP; P2X4 receptor; antagonist; clinical datasets; prostate cancer; purinergic signalling; xenograft model
Dates:
  • Accepted: 18 November 2020
  • Published (online): 20 November 2020
  • Published: 20 November 2020
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 03 Dec 2020 11:16
Last Modified: 04 Dec 2020 09:55
Status: Published
Publisher: MDPI AG
Refereed: Yes
Identification Number: https://doi.org/10.3390/cells9112511
Related URLs:

Share / Export

Statistics